Results of conversion from sandimmune to neoral in stable pediatric liver transplant recipients after two years

By Dunn S.P.   Falkenstein K.   Pierson A.   Cooney G.F.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1962-1963

Elsevier

Access to resources Recommend Favorite

Effect of Conversion From Sandimmune to Neoral on Glomerular Filtration Rate in Stable Renal Transplant Recipients

By Steinmuller D.   Dougherty J.   Coutee J.   Surek D.   Swies G.   Lewis R.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 298-299

Elsevier

Access to resources Recommend Favorite

Conversion from sandimmune to neoral in renal transplant recipients: two-year experience

By Wilczek H.E.   &   9kesson P.   Warholm C.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1753-1755

Elsevier

Access to resources Recommend Favorite

Safety of conversion from cyclosporine sandimmune to cyclosporine neoral in stable liver transplant patients

By Baruch Y.   Assy N.   Kramsky R.   Enat R.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1852-1853

Elsevier

Access to resources Recommend Favorite

Conversion from the conventional cyclosporine formulation (sandimmune) to a new oral microemulsion (neoral) in stable liver transplant patients

By Dibo-Cohen J.M.   Conort O.   Conti F.   Bernard D.   Hazebroucq G.   Calmus Y.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1857-1857

Elsevier

Access to resources Recommend Favorite